Key Takeaways: How Wegovy Works

Primary Action: Mimics natural GLP-1 hormone, activating receptors in the brain that control appetite.
Appetite Suppression: Reduces hunger, increases fullness, and lowers food cravings.
Gastric Emptying: Slows stomach emptying, prolonging satiety after meals.
Chemical Structure: Semaglutide, a 31-amino acid peptide with fatty acid side chain for prolonged action.
Metabolic Effect: Lowers body weight, improves cardiovascular risk factors.
Duration: Once‑weekly injection maintains steady drug levels.

Wegovy works by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1) that your gut releases after eating. It targets appetite centres in the brain, making you feel fuller and less hungry, so you naturally eat less. This guide explains the science behind semaglutide’s chemical composition, exact mechanism, and how it produces sustained weight loss.

Important Medical Advice

If you experience severe abdominal pain that may move to your back (possible pancreatitis), difficulty breathing or swelling of face/lips (severe allergic reaction), or vision changes (diabetic retinopathy), seek immediate medical attention. Do not use Wegovy if you have a personal or family history of medullary thyroid cancer.

Wegovy's Chemical Composition & Molecular Structure

The active substance in Wegovy is semaglutide, a synthetic analogue of human GLP-1. It is produced by recombinant DNA technology in yeast cells.

Chemical Structure Details

INN / Name

Semaglutide (C₁₈₇H₂₉₁N₄₅O₅₉)

A 31-amino acid peptide with a C-18 fatty diacid side chain attached to lysine at position 26. This lipidation enables binding to albumin and extends half-life.

Molecular Weight

Approximately 4.1 kDa

The large size and fatty acid chain prevent rapid kidney clearance, allowing once‑weekly dosing.

Excipients

Disodium phosphate dihydrate, propylene glycol, phenol, water for injection

pH adjusted with sodium hydroxide/hydrochloric acid. Each pen delivers 0.25 mg to 2.4 mg per dose.

The semaglutide molecule is engineered to resist degradation by the enzyme DPP‑4, giving it a long half-life of about one week. This structural modification is key to its once‑weekly subcutaneous administration.

🔬 Pharmaceutical Insight: Compared to natural GLP‑1 (half-life 2 minutes), semaglutide’s albumin binding protects it from breakdown, making sustained appetite suppression possible.

Mechanism of Action: How Wegovy Reduces Appetite

Wegovy works through three primary physiological pathways:

Brain (hypothalamus): Semaglutide activates GLP‑1 receptors in appetite-regulating centres, increasing feelings of fullness (satiety) and reducing hunger.
Stomach: It slows gastric emptying, so food stays longer in the stomach, prolonging satiety after meals.
Reward centres: It may reduce food cravings by acting on brain areas involved in reward and pleasure from food.

Step-by-Step Cellular Action

Step	Normal Physiology	Wegovy Effect
1. GLP-1 release	Intestinal L-cells release GLP-1 after eating	Wegovy provides constant GLP-1 activation throughout the week
2. Receptor binding	GLP-1 binds to receptors in pancreas, brain, gut	Semaglutide binds with high affinity to same receptors
3. Signal transduction	cAMP production, neuronal firing modulation	Enhanced and prolonged signalling
4. Outcome	Temporary appetite suppression	Sustained reduction in calorie intake

Importantly, Wegovy only works when used alongside a reduced-calorie diet and increased physical activity – it enhances your efforts, but does not replace them.

Metabolic Effects & Duration in the Body

Semaglutide induces weight loss by reducing energy intake, not by increasing metabolic rate. However, it has beneficial metabolic effects beyond weight:

Improves glycaemic control (lowers HbA1c)
Reduces systolic blood pressure
Improves lipid profile (reduces triglycerides)
Decreases inflammation markers

Time Course of Action (after 2.4 mg maintenance dose)

Peak concentration: 1–3 days post-injection
Steady state: Achieved after 4–5 weeks of once-weekly dosing
Half-life: ~1 week (6–7 days)
Duration of effect: Appetite suppression lasts the full week; if you miss a dose, effects gradually wear off after 2 weeks.

Because of the long half-life, it takes 5–6 weeks to reach full effect after each dose escalation.

Absorption, Distribution & Elimination

Absorption

Bioavailability: 89% after subcutaneous injection. Maximum concentration reached in 1–3 days. No food interaction.

Distribution

Volume of distribution: ~12.5 L. Extensively bound to albumin (>99%) – this slow release gives long action.

Elimination

Half-life: ~1 week. Metabolised by proteolysis into small peptides, excreted via urine and faeces. No CYP interactions.

Special populations: No dose adjustment for mild/moderate renal or hepatic impairment. Avoid in severe renal impairment (eGFR <15).

Clinical Efficacy for Weight Management

In the STEP trials, adults using Wegovy 2.4 mg lost an average of 15–17% of their body weight after 68 weeks, compared to 2.5% with placebo. Key efficacy data:

Outcome	Wegovy (2.4 mg)	Placebo
≥5% weight loss	86%	31%
≥10% weight loss	69%	12%
≥15% weight loss	50%	5%

For adolescents (12+ years) with obesity, Wegovy plus lifestyle intervention resulted in a 16% BMI reduction after 68 weeks.

Wegovy & Cardiovascular Risk Reduction

Wegovy is also indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal heart attack, non-fatal stroke) in adults with established cardiovascular disease and either overweight or obesity. The SELECT trial showed a 20% risk reduction independent of baseline weight loss, suggesting direct vascular benefits.

❤️ Cardio insight: The mechanism may involve anti-inflammatory effects, improved endothelial function, and reduced plaque progression.

Wegovy Mechanism FAQs

Does Wegovy work by boosting metabolism?

No, Wegovy primarily reduces appetite and calorie intake, not metabolic rate. It makes you feel fuller and less hungry, so you eat less.

How long does Wegovy stay in your system?

Wegovy has a half-life of about one week, so it takes 5–6 weeks to be completely eliminated after your last dose.

Can Wegovy cause low blood sugar?

In people without diabetes, hypoglycaemia is uncommon. But if you take sulfonylureas or insulin, your dose may need adjustment to prevent hypos.

Why does Wegovy cause nausea?

Nausea is a common side effect because Wegovy slows gastric emptying and activates brain receptors. It usually improves with gradual dose escalation.

Is Wegovy the same as Ozempic?

Both contain semaglutide, but Wegovy is specifically approved for weight management at higher doses (up to 2.4 mg), while Ozempic is for type 2 diabetes (up to 1 mg).

Start Your Weight Loss Journey with Wegovy

If Wegovy sounds like a suitable option, begin with a confidential online consultation with a UK-registered doctor. They will check your BMI, medical history, and guide you through the dose escalation.